Short peptide with an inhibitory activity on the NMDA/Gly-induced currents

References

• https://www.who.int/en/news-room/fact-sheets/detail/depression
   Google Scholar
• J.F. Greden, The burden of disease for treatment-resistant depression, J. Clin. Psychiat. 62 (2001), pp. 26–31.
   PubMed Web of Science ®Google Scholar
• C.B. Nemeroff, Prevalence and management of treatment-resistant depression, J. Clin. Psychiat. 68 (2007), pp. 17–25.
   PubMed Web of Science ®Google Scholar
• Y. Sattar, J. Wilson, A.M. Khan, M. Adnan, D. Azzopardi Larios, S. Shrestha, Q. Rahman, Z. Mansuri, A. Hassan, N.B. Patel, N. Tariq, S. Latchana, S.C. Lopez Pantoja, S. Vargas, N.A. Shaikh, F. Syed, D. Mittal, and F. Rumesa, A review of the mechanism of antagonism of N-methyl-D-aspartate receptor by ketamine in treatment-resistant depression, Cureus 10 (2018), pp. e2652.
   PubMed Web of Science ®Google Scholar
• B. Moghaddam, B. Adams, A. Verma, and D. Daly, Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex, J. Neurosci. 17 (1997), pp. 2921–2927. doi:10.1523/JNEUROSCI.17-08-02921.1997.
   PubMed Web of Science ®Google Scholar
• D. Stroebel, D.L. Buhl, J.D. Knafels, P.K. Chanda, M. Green, S. Sciabola, L. Mony, P. Paoletti, and J.A. Pandit, Novel binding mode reveals two distinct classes of NMDA receptor GluN2B-selective antagonists, Mol. Pharmacol. 89 (2006), pp. 541–551. doi:10.1124/mol.115.103036.
   Google Scholar
• C.N. Haile, J.W. Murrough, D.V. Iosifescu, L.C. Chang, R.K. Al Jurdi, A. Foulkes, S. Iqbal, J.J. Mahoney, R. De La Garza, D.S. Charney, T.F. Newton, and S.J. Mathew, Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression, Int. J. Neuropsychopharmacol. 17 (2014), pp. 331–336. doi:10.1017/S1461145713001119.
   PubMed Web of Science ®Google Scholar
• J.A. Siuciak, D.R. Lewis, S.J. Wiegand, and R.M. Lindsay, Antidepressant-like effect of brain-derived neurotrophic factor (BDNF), Pharmacol. Biochem. Behav. 56 (1997), pp. 131–137. doi:10.1016/S0091-3057(96)00169-4.
   PubMed Web of Science ®Google Scholar
• S.F. Traynelis, L.P. Wollmuth, C.J. McBain, F.S. Menniti, K.M. Vance, K.K. Ogden, K.B. Hansen, H. Yuan, S.J. Myers, and R. Dingledine, Glutamate receptor ion channels: Structure, regulation, and function, Pharmacol. Rev. 62 (2010), pp. 405–496. doi:10.1124/pr.109.002451.
   PubMed Web of Science ®Google Scholar
• R.S. Petralia and R.J. Wenthold, NMDA receptors, in The Glutamate Receptors, R.W. Gereau and G.T. Swanson, eds., Humana Press, Totowa, NJ, 2008, pp. 45–98.
   Google Scholar
• B. Gotti, D. Duverger, J. Bertin, C. Carter, R. Dupont, J. Frost, B. Gaudilliere, E.T. MacKenzie, J. Rousseau, and B. Scatton, Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia, J. Pharmacol. Exp. Ther. 247 (1988), pp. 1211–1221.
   PubMed Web of Science ®Google Scholar
• J.R. Moskal, A.G. Kuo, C. Weiss, P.L. Wood, A. O’Connor Hanson, S. Kelso, R.B. Harris, and J.F. Disterhoft, GLYX-13: A monoclonal antibody-derived peptide that acts as an N-methyl-d-aspartate receptor modulator, Neuropharmacology 49 (2005), pp. 1077–1087. doi:10.1016/j.neuropharm.2005.06.006.
   PubMed Web of Science ®Google Scholar
• J.R. Moskal, J.S. Burgdorf, P.K. Stanton, R.A. Kroes, J.F. Disterhoft, R.M. Burch, and M. Amin Khan, The development of rapastinel (formerly GLYX-13); A rapid acting and long lasting antidepressant, Curr. Neuropharmacol. 15 (2007), pp. 47–56. doi:10.2174/1570159X14666160321122703.
   Google Scholar
• R.-M. Ragguett, C. Rong, K. Kratiuk, and R.S. McIntyre, Rapastinel – an investigational NMDA-R modulator for major depressive disorder: Evidence to date, Expert Opin. Investig. Drugs 28 (2009), pp. 113–119. doi:10.1080/13543784.2019.1559295.
   Google Scholar
• https://www.molinspiration.com/services/logp.html
   Google Scholar
• O. Trott and A.J. Olson, AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J. Comput. Chem. 31 (2010), pp. 455–461.
   PubMed Web of Science ®Google Scholar
• A. Jakalian, B.L. Bush, D.B. Jack, and C.I. Bayly, Fast, efficient generation of high-quality atomic charges. AM1-BCC Model: I. Method, J. Comput. Chem. 21 (2000), pp. 132–146. doi:10.1002/(SICI)1096-987X(20000130)21:2<>1.0.CO;2-6.
   Web of Science ®Google Scholar
• J. Wang, R.M. Wolf, J.W. Caldwell, P.A. Kollman, and D.A. Case, Development and testing of a general amber force field, J. Comput. Chem. 25 (2004), pp. 1157–1174. doi:10.1002/(ISSN)1096-987X.
   PubMed Web of Science ®Google Scholar
• Z. Tan, A. Spasic, and D.H. Mathews, 96 benchmark of amber FF12SB force field by comparison of estimated hairpin loop folding stabilities to experiments, J. Biomol. Struct. Dyn. 33 (2015), pp. 61–62. doi:10.1080/07391102.2015.1032713.
   PubMed Web of Science ®Google Scholar
• D.J. Sindhikara, N. Yoshida, and F. Hirata, Placevent: An algorithm for prediction of explicit solvent atom distribution—application to HIV-1 protease and F-ATP synthase, J. Comput. Chem. 33 (2012), pp. 1536–1543. doi:10.1002/jcc.v33.18.
   PubMed Web of Science ®Google Scholar
• R. Salomon-Ferrer, A.W. Götz, D. Poole, S. Le Grand, and R.C. Walker, Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh ewald, J. Chem. Theor. Comput. 9 (2013), pp. 3878–3888. doi:10.1021/ct400314y.
   PubMed Web of Science ®Google Scholar
• N. Homeyer and H. Gohlke, Free energy calculations by the molecular mechanics Poisson−Boltzmann surface area method, Mol. Inform. 31 (2012), pp. 114–122. doi:10.1002/minf.201100135.
   PubMed Web of Science ®Google Scholar
• T.E. Balius, M. Fischer, R.M. Stein, T.B. Adler, C.N. Nguyen, A. Cruz, M.K. Gilson, T. Kurtzman, and B.K. Shoichet, Testing inhomogeneous solvation theory in structure-based ligand discovery, Proc. Natl. Acad. Sci. U.S.A. 114 (2017), pp. E6839–E6846. doi:10.1073/pnas.1703287114.
   PubMed Web of Science ®Google Scholar
• F. Albericio, Solid-Phase Synthesis: A Practical Guide, 1st ed., CRC Press, Boca Raton, 2000.
   Google Scholar
• S.M. Jones, L.D. Snell, and K.M. Johnson, Characterization of the binding of radioligands to the N-methyl-D-aspartate, phencyclidine, and glycine receptors in buffy coat membranes, J. Pharmacol. Meth. 21 (1989), pp. 161–168. doi:10.1016/0160-5402(89)90034-X.
   PubMedGoogle Scholar
• V.S. Vorobjev, Vibrodissociation of sliced mammalian nervous tissue, J. Neurosci. Meth. 38 (1991), pp. 145–150. doi:10.1016/0165-0270(91)90164-U.
   PubMed Web of Science ®Google Scholar
• H.J. Böhm, The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure, J. Comput. Aided Mol. Des. 8 (1994), pp. 243–256. doi:10.1007/BF00126743.
   PubMed Web of Science ®Google Scholar
• F. Jalali-Yazdi, S. Chowdhury, C. Yoshioka, and E. Gouaux, Mechanisms for zinc and proton inhibition of the GluN1/GluN2A NMDA receptor, Cell 175 (2018), pp. 1520–1532.e15. doi:10.1016/j.cell.2018.10.043.
   PubMed Web of Science ®Google Scholar
• E. Karakas, N. Simorowski, and H. Furukawa, Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors, Nature 475 (2011), pp. 249–253. doi:10.1038/nature10180.
   PubMed Web of Science ®Google Scholar
• D. Karlov, E. Radchenko, A. Zefirov, V. Palyulin, V. Pentkovski, and N. Zefirov, On mechanism of allosteric modulation of NMDA receptor via amino-terminal domains, Biochem. Biophys. Res. Commun. 424 (2012), pp. 687–690. doi:10.1016/j.bbrc.2012.07.009.
   PubMed Web of Science ®Google Scholar
• M.C. Regan, Z. Zhu, H. Yuan, S.J. Myers, D.S. Menaldino, Y.A. Tahirovic, D.C. Liotta, S.F. Traynelis, and H. Furukawa, Structural elements of a pH-sensitive inhibitor binding site in NMDA receptors, Nat. Commun. 10 (2019), pp. 321.
   Google Scholar
• D.S. Karlov, M.I. Lavrov, V.A. Palyulin, and N.S. Zefirov, MM-GBSA and MM-PBSA performance in activity evaluation of AMPA receptor positive allosteric modulators, J. Biomol. Struct. Dyn. 36 (2018), pp. 2508–2516. doi:10.1080/07391102.2017.1360208.
   PubMed Web of Science ®Google Scholar
• E. Pinard, A. Alanine, A. Bourson, B. Büttelmann, M.-P. Heitz, V.R.G. Mutel, G. Trube, and R. Wyler, 4-Aminoquinolines as a novel class of NR1/2B subtype selective NMDA receptor antagonists, Bioorg. Med. Chem. Lett. 12 (2002), pp. 2615–2619. doi:10.1016/S0960-894X(02)00470-5.
   PubMed Web of Science ®Google Scholar
• G. Klebe, Applying thermodynamic profiling in lead finding and optimization, Nat. Rev. Drug Discov. 14 (2015), pp. 95–110. doi:10.1038/nrd4486.
   PubMed Web of Science ®Google Scholar
• J.N.C. Kew, J.G. Richards, V. Mutel, and J.A. Kemp, Developmental changes in NMDA receptor glycine affinity and ifenprodil sensitivity reveal three distinct populations of NMDA receptors in individual rat cortical neurons, J. Neurosci. 18 (1998), pp. 1935–1943. doi:10.1523/JNEUROSCI.18-06-01935.1998.
   PubMed Web of Science ®Google Scholar